Log in
Water-soluble vitamin

Vitamin C

Vitamin C (ascorbic acid) is an essential water-soluble vitamin and antioxidant required for collagen synthesis, immune function, and iron absorption. It is primarily used to prevent and treat scurvy, a deficiency disease characterized by impaired collagen formation. The most testable fact is that vitamin C deficiency causes scurvy with the classic triad of perifollicular hemorrhage, corkscrew hairs, and bleeding gums.

Drug classWater-soluble vitamin, antioxidant
MechanismCofactor for hydroxylase enzymes in collagen synthesis
Main usesScurvy prevention and treatment, dietary supplementation
Key adverse effectOsmotic diarrhea with high doses, oxalate stones
7 min readFor medical studentsUpdated 2026-10-14

Mechanism of action

Vitamin C (ascorbic acid) functions as a cofactor for several enzymatic reactions and as a powerful reducing agent and antioxidant.

Collagen synthesis

Vitamin C serves as an essential cofactor for prolyl hydroxylase and lysyl hydroxylase, enzymes that hydroxylate proline and lysine residues in procollagen. This hydroxylation is critical for the proper cross-linking and stabilization of collagen triple helix structure. Without adequate vitamin C, defective collagen is produced, leading to the clinical manifestations of scurvy including poor wound healing, capillary fragility, and bleeding.

Antioxidant function

As a reducing agent, vitamin C scavenges reactive oxygen species and protects cellular components from oxidative damage. It regenerates other antioxidants including vitamin E and glutathione, maintaining cellular redox balance.

Iron absorption

Vitamin C enhances non-heme iron absorption in the gastrointestinal tract by reducing ferric iron (Fe³⁺) to ferrous iron (Fe²⁺), the more readily absorbed form. This is particularly important for iron absorption from plant-based sources.

Neurotransmitter and hormone synthesis

Vitamin C acts as a cofactor for dopamine β-hydroxylase (converting dopamine to norepinephrine) and for enzymes involved in carnitine and peptide hormone synthesis.

High-yield for exams
  • Vitamin C deficiency causes scurvy: perifollicular hemorrhage, corkscrew hairs, bleeding gums, poor wound healing
  • Vitamin C is a cofactor for prolyl and lysyl hydroxylase enzymes required for collagen cross-linking
  • Vitamin C enhances non-heme iron absorption by reducing Fe³⁺ to Fe²⁺ in the gut
  • High-dose vitamin C causes osmotic diarrhea and increases oxalate kidney stone risk
  • Vitamin C can precipitate hemolytic anemia in patients with G6PD deficiency at high doses
  • Coagulation studies (PT/PTT) are normal in scurvy; bleeding is due to capillary fragility, not coagulopathy
  • Smokers require additional vitamin C due to increased oxidative stress
  • Vitamin C is water-soluble; excess is renally excreted, making toxicity rare at normal doses

Indications

Scurvy prevention and treatment: The primary indication for vitamin C supplementation is prevention and treatment of scurvy in patients with inadequate dietary intake. Risk groups include elderly individuals with poor nutrition, alcoholics, patients on restrictive diets, and those with malabsorption syndromes.

Dietary supplementation: Used as a nutritional supplement in populations at risk of deficiency, including pregnant and lactating women, smokers (who have increased vitamin C turnover), and patients with chronic illnesses.

Methemoglobinemia: Used as an adjunct in certain cases of methemoglobinemia, particularly when methylene blue is contraindicated or ineffective.

Enhancement of iron absorption: Co-administered with oral iron supplements to enhance absorption of non-heme iron in patients with iron deficiency anemia.

Investigational uses: While vitamin C has been studied for prevention of upper respiratory infections, wound healing enhancement, and adjunctive cancer therapy, evidence for these indications remains limited and controversial. High-dose intravenous vitamin C is being investigated in critical care settings but is not standard therapy.

Pharmacokinetics

Absorption: Vitamin C is absorbed in the small intestine via active transport (sodium-dependent vitamin C transporters, SVCT1) at physiologic doses and passive diffusion at higher doses. Absorption is saturable; bioavailability decreases as dose increases, with approximately 70-90% absorbed at low doses but declining to less than 50% at high doses.

Distribution: Vitamin C distributes widely throughout body tissues with highest concentrations in the adrenal glands, pituitary, brain, leukocytes, and eyes. It is not significantly protein-bound.

Metabolism: Vitamin C is oxidized to dehydroascorbic acid, which can be reduced back to ascorbic acid or further metabolized to oxalate and other metabolites.

Elimination: Eliminated primarily via the kidneys. At physiologic plasma concentrations, renal tubular reabsorption is efficient. Once plasma concentrations exceed the renal threshold (approximately 1.2-1.5 mg/dL), excess vitamin C is excreted unchanged in urine. The half-life is approximately 10-20 days at normal body stores.

Body stores: Total body pool in adults is approximately 1500-2000 mg. Daily turnover is about 3-4% of body stores. Scurvy develops when body stores fall below 300 mg, typically after 1-3 months of deficient intake.

Adverse effects

Vitamin C is generally well tolerated at recommended doses. Adverse effects are typically associated with high-dose supplementation.

Gastrointestinal effects

  • Osmotic diarrhea: The most common adverse effect at high doses, due to unabsorbed ascorbic acid in the intestinal lumen
  • Nausea and abdominal cramping: Occur with high oral doses
  • Gastroesophageal reflux: May be exacerbated by the acidity of ascorbic acid

Renal effects

  • Oxalate nephrolithiasis: Vitamin C is metabolized to oxalate; chronic high-dose supplementation may increase urinary oxalate excretion and risk of calcium oxalate kidney stones, particularly in susceptible individuals
  • Uric acid stones: High doses may acidify urine and increase uric acid crystallization risk

Hematologic effects

  • Hemolysis in G6PD deficiency: High doses can cause oxidative stress and precipitate hemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency
  • Iron overload: Enhanced iron absorption may worsen iron overload in patients with hemochromatosis or thalassemia

Laboratory interference

  • False-negative stool guaiac tests: High doses may cause false-negative results for fecal occult blood
  • False glucose readings: Can interfere with certain glucose monitoring systems (historically more common with older glucose oxidase-based methods)

Other effects

  • Rebound scurvy: Abrupt discontinuation after chronic high-dose use may theoretically precipitate scurvy symptoms due to adaptive downregulation of vitamin C transport, though this is rare and controversial

Contraindications and warnings

Absolute contraindications:

  • Known hypersensitivity to ascorbic acid or formulation components (rare)

Relative contraindications and precautions:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency: High doses may precipitate hemolytic anemia; use with caution and avoid doses exceeding the RDA
  • Hemochromatosis and iron overload disorders: Enhanced iron absorption may worsen iron accumulation; monitor iron status
  • Hyperoxaluria and recurrent calcium oxalate nephrolithiasis: High doses may increase oxalate production and stone risk; limit supplementation
  • Renal insufficiency: Oxalate accumulation risk is increased; avoid high doses in patients with severe renal impairment
  • Sickle cell disease: Theoretical concern that high doses may increase oxidative stress, though clinical significance is unclear

Pregnancy and lactation: Vitamin C is pregnancy category A (safe at recommended dietary allowances) but category C at high doses. Requirements increase during pregnancy and lactation. High-dose supplementation during pregnancy is not recommended and may theoretically cause rebound scurvy in the newborn.

Pediatric use: Safe at age-appropriate doses. Excessive supplementation should be avoided.

Special populations: Smokers have increased vitamin C requirements due to increased oxidative stress and metabolic turnover.

Drug interactions

Medications whose effects are altered by vitamin C

Iron supplements: Vitamin C significantly enhances absorption of non-heme iron by maintaining iron in the reduced ferrous state. This interaction is therapeutically beneficial when treating iron deficiency but may be problematic in iron overload states.

Warfarin: High doses of vitamin C may decrease warfarin effectiveness, possibly by increasing hepatic metabolism or reducing absorption. INR should be monitored if high-dose vitamin C is started or stopped.

Aluminum-containing antacids: Vitamin C may increase aluminum absorption from antacids, potentially increasing aluminum toxicity risk, particularly in patients with renal impairment.

Chemotherapy agents: The interaction with chemotherapy is complex and controversial. Some in vitro studies suggest high-dose vitamin C may reduce efficacy of certain alkylating agents, while others suggest potential benefit. Patients undergoing chemotherapy should consult their oncologist before using vitamin C supplements.

Medications that affect vitamin C levels

Aspirin and NSAIDs: Chronic use may decrease vitamin C levels through increased urinary excretion.

Oral contraceptives: May decrease plasma vitamin C concentrations, though clinical significance is unclear.

Corticosteroids: Chronic use may increase vitamin C requirements.

Smoking: Not a drug interaction per se, but tobacco smoke depletes vitamin C, increasing requirements.

Laboratory test interactions

High doses may interfere with urine glucose tests, stool guaiac tests, and certain serum chemistry measurements. Inform laboratory personnel if taking high-dose supplements.

Clinical pearls

  • Scurvy diagnosis: The classic triad is perifollicular hemorrhage, corkscrew hairs, and bleeding gums with tooth loss. Additional findings include poor wound healing, hyperkeratotic papules, and hemarthrosis. Mental status changes and the 4 H's (hemorrhagic manifestations, hyperkeratosis, hematologic abnormalities, hemarthrosis) help recall features.
  • High-risk populations for deficiency: Remember the mnemonic "SCURVY" - Smokers, Children with restricted diets, Undernutrition/eating disorders, Renal dialysis patients, Veterans/elderly with poor intake, You (anyone with malabsorption).
  • Scurvy vs. other bleeding disorders: Unlike coagulopathies, platelet count and coagulation studies (PT/PTT) are normal in scurvy. The bleeding is due to capillary fragility from defective collagen, not a clotting defect.
  • Wound healing: Vitamin C deficiency impairs wound healing because of defective collagen synthesis. Consider screening for deficiency in patients with poor wound healing, especially if other risk factors are present.
  • Perifollicular hemorrhage: This finding is highly specific for scurvy and results from fragile capillaries around hair follicles. The corkscrew hairs occur because defective collagen in the follicle distorts hair shaft formation.
  • Rapid response to treatment: Scurvy symptoms improve remarkably quickly with vitamin C supplementation—gingival bleeding may resolve within 24-48 hours, and most other symptoms resolve within weeks.
  • Iron absorption enhancement: Always counsel patients taking oral iron for deficiency to take it with vitamin C (e.g., orange juice) to maximize absorption. Conversely, tea and calcium inhibit absorption.
  • Megadose myths: Despite popular belief, high-dose vitamin C supplementation has not been conclusively shown to prevent or treat the common cold in the general population, though modest benefit may exist in marathon runners and those under extreme physical stress.
  • Urinary acidification: Vitamin C supplementation acidifies urine, which may be useful in managing certain urinary tract infections but can also increase uric acid precipitation.
  • Don't forget dietary sources: Citrus fruits, strawberries, kiwi, bell peppers, broccoli, and tomatoes are excellent sources. Fresh fruits and vegetables are best; vitamin C is destroyed by prolonged storage, cooking, and light exposure.
Mnemonic

SCURVY for deficiency risk groups: Smokers, Children with restricted diets, Undernutrition/eating disorders, Renal dialysis, Veterans/elderly with poor intake, You (malabsorption). For scurvy signs, remember the 4 H's: Hemorrhage (perifollicular), Hyperkeratosis, Hematologic changes, Hemarthrosis.

Practice questions

1. A 62-year-old man with a history of alcoholism presents with easy bruising, fatigue, and bleeding gums for the past 3 months. He reports eating mostly canned foods and rarely consuming fresh fruits or vegetables. Physical examination reveals multiple perifollicular hemorrhages on his lower extremities, corkscrew hairs, and gingival bleeding with several loose teeth. Laboratory studies show hemoglobin 10.2 g/dL, normal platelet count, PT 12.5 seconds (normal), and PTT 32 seconds (normal). Which of the following is the most likely diagnosis?

Answer: C. This patient has scurvy (vitamin C deficiency) presenting with the classic triad of perifollicular hemorrhage, corkscrew hairs, and bleeding gums, along with risk factors (alcoholism, poor dietary intake). Crucially, his coagulation studies are normal, which distinguishes scurvy from coagulopathies. The bleeding in scurvy results from capillary fragility due to defective collagen synthesis, not from clotting factor deficiencies. Hemophilia A and vitamin K deficiency would show prolonged PTT and PT respectively, liver cirrhosis would show multiple abnormal coagulation parameters, and thrombocytopenia would show low platelet count.

2. A 45-year-old woman with a history of gastric bypass surgery 2 years ago presents with poor wound healing after a minor surgical procedure 6 weeks ago. She also reports fatigue and occasional gum bleeding when brushing her teeth. She follows a restrictive diet and rarely eats fruits or vegetables. Physical examination shows delayed wound healing with friable granulation tissue and several ecchymoses on her legs. Which of the following mechanisms best explains her presentation?

Answer: C. This patient likely has vitamin C deficiency (scurvy) from malabsorption after gastric bypass and poor dietary intake. Vitamin C is an essential cofactor for prolyl hydroxylase and lysyl hydroxylase, enzymes that hydroxylate proline and lysine residues in procollagen. Without adequate hydroxylation, defective collagen is produced, leading to impaired wound healing, capillary fragility (easy bruising), and bleeding gums. The other options describe different coagulation or vascular problems but do not explain the constellation of findings in this patient with clear risk factors for vitamin C deficiency.

3. A 35-year-old man with glucose-6-phosphate dehydrogenase (G6PD) deficiency is taking high-dose vitamin C supplements recommended by a friend for 'immune support.' He presents to the emergency department with fatigue, dark urine, and jaundice that started 2 days ago. Laboratory studies show hemoglobin 7.8 g/dL (baseline 14 g/dL), elevated indirect bilirubin, elevated LDH, low haptoglobin, and hemoglobinuria. Peripheral smear shows bite cells and Heinz bodies. What is the most likely mechanism of this patient's presentation?

Answer: C. This patient is experiencing acute hemolytic anemia triggered by high-dose vitamin C in the setting of G6PD deficiency. Although vitamin C is an antioxidant at normal doses, at very high doses it can paradoxically generate reactive oxygen species and increase oxidative stress. Patients with G6PD deficiency lack adequate glutathione reductase activity to handle oxidative stress, making their red blood cells vulnerable to oxidative damage and hemolysis. The bite cells and Heinz bodies on smear, along with hemoglobinuria and elevated indirect bilirubin, confirm intravascular hemolysis. This is a known but uncommon adverse effect of megadose vitamin C supplementation in G6PD-deficient individuals.

Frequently asked questions

How does vitamin C work in the body?

Vitamin C functions as a cofactor for hydroxylase enzymes that are essential for collagen synthesis, specifically prolyl and lysyl hydroxylase. These enzymes hydroxylate proline and lysine residues in procollagen, allowing proper cross-linking and stabilization of the collagen triple helix. Additionally, vitamin C acts as a powerful antioxidant, scavenges free radicals, enhances non-heme iron absorption by reducing ferric to ferrous iron, and serves as a cofactor in neurotransmitter synthesis including the conversion of dopamine to norepinephrine.

What are the side effects of vitamin C?

Vitamin C is very safe at recommended doses. At high doses, the most common side effect is osmotic diarrhea due to unabsorbed ascorbic acid in the intestine, along with nausea and abdominal cramping. Chronic high-dose use increases risk of calcium oxalate kidney stones because vitamin C is metabolized to oxalate. In patients with G6PD deficiency, high doses can cause hemolytic anemia. Vitamin C may also cause false-negative stool guaiac tests and can enhance iron absorption, which may worsen iron overload in susceptible individuals.

What are the signs and symptoms of vitamin C deficiency (scurvy)?

Scurvy presents with the classic triad of perifollicular hemorrhage (bleeding around hair follicles), corkscrew hairs (distorted hair shafts), and bleeding gums with loosening teeth. Other manifestations include poor wound healing, easy bruising, petechiae, hemarthrosis (joint bleeding), hyperkeratotic papules, and fatigue. In severe cases, patients may develop anemia and mental status changes. The bleeding occurs due to capillary fragility from defective collagen synthesis, not from coagulation defects, so PT/PTT remain normal. Risk groups include elderly with poor nutrition, alcoholics, smokers, and patients on restrictive diets.

Can you take too much vitamin C?

Yes, though vitamin C toxicity is rare because it is water-soluble and excess is excreted in urine. However, chronic high-dose intake can cause osmotic diarrhea, nausea, and abdominal discomfort. More concerning is the increased risk of calcium oxalate kidney stones with prolonged high-dose use, as vitamin C is metabolized to oxalate. In patients with G6PD deficiency, high doses can trigger hemolytic anemia. Patients with hemochromatosis should avoid high doses because vitamin C enhances iron absorption and may worsen iron overload. The tolerable upper intake level is 2000 mg/day for adults.

Vitamin C vs vitamin E — what is the difference?

Vitamin C (ascorbic acid) and vitamin E (tocopherol) are both antioxidants but differ significantly. Vitamin C is water-soluble, functions in aqueous environments, and serves as a cofactor for collagen synthesis enzymes; deficiency causes scurvy. Vitamin E is fat-soluble, protects cell membranes from lipid peroxidation, and deficiency causes neurologic problems including peripheral neuropathy and ataxia, not scurvy. Vitamin C enhances iron absorption and is excreted rapidly, while vitamin E accumulates in tissues and has a longer half-life. They work synergistically—vitamin C can regenerate oxidized vitamin E, restoring its antioxidant capacity.

Conditions it is used for

ScurvyVitamin C deficiencyIron deficiency anemia (adjunct)Methemoglobinemia (adjunct)
Vitamin AVitamin B complexVitamin DVitamin EVitamin KFolic acidIron supplementsFerrous sulfate

Sources and further reading

DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A11GA01WHO ATC/DDD index: G01AD03

Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.